ADA Scientific Sessions 2026 Abstract
IBI3042: A Novel Oral Once-Weekly Small-Molecule GLP-1 Receptor Agonist for Type 2 Diabetes and Obesity
Experiments in animalsInterventions
Papers by Jiali Ding
2 results
- ADA Scientific Sessions 2026 Abstract
IBI3032: An Orally Bioavailable Nonpeptidic GLP-1 Receptor Agonist Advancing through Phase 1 Clinical Trials
Experiments in animalsInterventions